Patent ID: 8034551
Filing Date: 2011-10-11
Classification: G01N,Y02A

Abstract:
1. A method for identifying the presence and/or severity of erythrocyte stage malaria disease in a subject animal, comprising: obtaining a sample of urine from the subject animal; contacting the urine sample from the subject animal with an antibody to a liver-type fatty acid binding protein (L-FABP), wherein the antibody binds to L-FABP present in the urine; detecting binding of the antibody and the L-FABP in the urine sample; and quantifying the amount of antibody bound to L-FABP present in the urine sample, wherein the presence of an amount of antibody bound to L-FABP in an amount greater than an average amount of L-FABP present in urine from control animals not infected with malaria indicates the presence of erythrocyte malaria in the subject animal.